Literature DB >> 15030518

Regulation of complement C3 and C4 synthesis in human peritoneal mesothelial cells by peritoneal dialysis fluid.

S Tang1, J C K Leung, L Y Y Chan, A W L Tsang, C X R Chen, W Zhou, K N Lai, S H Sacks.   

Abstract

Although complement is activated in the peritoneal cavity during chronic peritoneal dialysis (PD), little is known about its role in peritoneal defence and injury related to long-term PD. We examined the impact of glucose and commercial peritoneal dialysis solutions on complement expression in HPMCs obtained by primary culture from omental tissues of consented patients undergoing elective abdominal surgery. Constitutive expression of C3 and C4 mRNA in HPMCs was up-regulated upon exposure to 75 mm glucose in a time-dependent manner. C3 and C4 protein was secreted in both apical and basolateral directions. Glucose doses beyond 100 mm markedly down-regulated C3 and C4 expression, and stimulated LDH release dose-dependently. Such cytotoxic effects were attenuated using equivalent doses of mannitol instead of glucose. Treatment with conventional lactate-buffered dialysis solution gave rise to down-regulation of C3 and C4 expression, and heightened LDH release in HPMCs. These effects correlated with the glucose strength of the solution, persisted despite replacement with a bicarbonate-buffered solution, aggravated by glycated albumin, and were partially abrogated by supplementation with 10% fetal bovine serum in the culture system. Our findings suggest that the artificial conditions imposed by PD lead to alterations in local complement synthesis that have implications for the role of the peritoneal mesothelium in both inflammation and defence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15030518      PMCID: PMC1808994          DOI: 10.1111/j.1365-2249.2004.02407.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

Review 1.  Complement. First of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

Review 2.  Peritoneal defenses against infection: winning the battle but losing the war?

Authors:  R J Faull
Journal:  Semin Dial       Date:  2000 Jan-Feb       Impact factor: 3.455

Review 3.  Long-term peritoneal membrane changes.

Authors:  G A Coles; N Topley
Journal:  Adv Ren Replace Ther       Date:  2000-10

4.  Ingestion of Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli by human peritoneal mesothelial cells.

Authors:  C E Visser; J J Brouwer-Steenbergen; I L Schadee-Eestermans; S Meijer; R T Krediet; R H Beelen
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

5.  Staphylococcal exoproducts down-regulate cyclooxygenase 1 and 2 in peritoneal macrophages.

Authors:  R K Mackenzie; N Topley; A Neubauer; G A Coles; J D Williams
Journal:  J Lab Clin Med       Date:  1997-01

Review 6.  Peritoneal dialysis fluid biocompatibility: does it really matter?

Authors:  A Jörres; G M Gahl; U Frei
Journal:  Kidney Int Suppl       Date:  1994-12       Impact factor: 10.545

7.  Effect of hyperosmolality upon the mesothelial monolayer exposed in vivo and in situ to a mannitol-enriched dialysis solution.

Authors:  L Gotloib; V Wajsbrot; A Shostak; R Kushnier
Journal:  Nephron       Date:  1999       Impact factor: 2.847

Review 8.  Biocompatibility of new peritoneal dialysis solutions: clinical experience.

Authors:  E Garcia-Lopez; B Lindholm; A Tranaeus
Journal:  Perit Dial Int       Date:  2000       Impact factor: 1.756

9.  Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells.

Authors:  Joseph C K Leung; Anita W L Tsang; Daniel T M Chan; Kar Neng Lai
Journal:  J Am Soc Nephrol       Date:  2000-02       Impact factor: 10.121

10.  Complement in serum and dialysate in children on continuous ambulatory peritoneal dialysis.

Authors:  R E Reddingius; C H Schröder; M R Daha; H L Willems; A M Koster; L A Monnens
Journal:  Perit Dial Int       Date:  1995       Impact factor: 1.756

View more
  11 in total

1.  Toll-Like Receptors 2 and 4 Are Potential Therapeutic Targets in Peritoneal Dialysis-Associated Fibrosis.

Authors:  Anne-Catherine Raby; Chantal S Colmont; Ann Kift-Morgan; Jörg Köhl; Matthias Eberl; Donald Fraser; Nicholas Topley; Mario O Labéta
Journal:  J Am Soc Nephrol       Date:  2016-07-18       Impact factor: 10.121

2.  Complement Activation in Peritoneal Dialysis-Induced Arteriolopathy.

Authors:  Maria Bartosova; Betti Schaefer; Justo Lorenzo Bermejo; Silvia Tarantino; Felix Lasitschka; Stephan Macher-Goeppinger; Peter Sinn; Bradley A Warady; Ariane Zaloszyc; Katja Parapatics; Peter Májek; Keiryn L Bennett; Jun Oh; Christoph Aufricht; Franz Schaefer; Klaus Kratochwill; Claus Peter Schmitt
Journal:  J Am Soc Nephrol       Date:  2017-10-18       Impact factor: 10.121

Review 3.  Primary and metastatic peritoneal surface malignancies.

Authors:  Delia Cortés-Guiral; Martin Hübner; Mohammad Alyami; Aditi Bhatt; Wim Ceelen; Olivier Glehen; Florian Lordick; Robert Ramsay; Olivia Sgarbura; Kurt Van Der Speeten; Kiran K Turaga; Manish Chand
Journal:  Nat Rev Dis Primers       Date:  2021-12-16       Impact factor: 52.329

Review 4.  Sterile Injury Repair and Adhesion Formation at Serosal Surfaces.

Authors:  Simone N Zwicky; Deborah Stroka; Joel Zindel
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

5.  Safety of Intraperitoneal Injection of Adipose Tissue-Derived Autologous Mesenchymal Stem Cells in Cats.

Authors:  M Parys; N Nelson; K Koehl; R Miller; J B Kaneene; J M Kruger; V Yuzbasiyan-Gurkan
Journal:  J Vet Intern Med       Date:  2015-10-29       Impact factor: 3.333

6.  High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Keiko Higashide; Yumi Sei; Daiki Iguchi; Fumiko Sakata; Masanobu Horie; Shoichi Maruyama; Seiichi Matsuo; B Paul Morgan; Yasuhiko Ito
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

Review 7.  The Complement System in Dialysis: A Forgotten Story?

Authors:  Felix Poppelaars; Bernardo Faria; Mariana Gaya da Costa; Casper F M Franssen; Willem J van Son; Stefan P Berger; Mohamed R Daha; Marc A Seelen
Journal:  Front Immunol       Date:  2018-01-25       Impact factor: 7.561

8.  Alteration of membrane complement regulators is associated with transporter status in patients on peritoneal dialysis.

Authors:  Daniel Kitterer; Dagmar Biegger; Stephan Segerer; Niko Braun; M Dominik Alscher; Joerg Latus
Journal:  PLoS One       Date:  2017-05-19       Impact factor: 3.240

Review 9.  The Peritoneum: Beyond the Tissue - A Review.

Authors:  Andres Isaza-Restrepo; Juan S Martin-Saavedra; Juan L Velez-Leal; Felipe Vargas-Barato; Rafael Riveros-Dueñas
Journal:  Front Physiol       Date:  2018-06-15       Impact factor: 4.566

Review 10.  Biocompatible Peritoneal Dialysis: The Target Is Still Way Off.

Authors:  Maria Bartosova; Claus Peter Schmitt
Journal:  Front Physiol       Date:  2019-01-07       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.